Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Non Operating Income (2016 - 2025)

Apyx Medical's Non Operating Income history spans 12 years, with the latest figure at -$1.2 million for Q4 2025.

  • For Q4 2025, Non Operating Income rose 23.98% year-over-year to -$1.2 million; the TTM value through Dec 2025 reached -$4.4 million, down 70.58%, while the annual FY2025 figure was -$4.4 million, 1.64% up from the prior year.
  • Non Operating Income reached -$1.2 million in Q4 2025 per APYX's latest filing, down from -$1.0 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $622000.0 in Q2 2022 to a low of -$4.6 million in Q4 2023.
  • Average Non Operating Income over 5 years is -$579500.0, with a median of -$186000.0 recorded in 2021.
  • Peak YoY movement for Non Operating Income: surged 760.0% in 2021, then tumbled 111400.0% in 2025.
  • A 5-year view of Non Operating Income shows it stood at -$184000.0 in 2021, then soared by 110.33% to $19000.0 in 2022, then plummeted by 24547.37% to -$4.6 million in 2023, then soared by 67.23% to -$1.5 million in 2024, then grew by 23.98% to -$1.2 million in 2025.
  • Per Business Quant, the three most recent readings for APYX's Non Operating Income are -$1.2 million (Q4 2025), -$1.0 million (Q3 2025), and -$1.1 million (Q2 2025).